CLCS
Price:
$0.38
Market Cap:
$17.11M
Cell Source, Inc., a biotechnology company, develops cell therapy treatments based on the management of immune tolerance. The company's lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is used in various applications, including treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptance, as well as treatment of end stage kidney disease and other non-malignant organ diseases, and various cancers and non-malignant diseases. Cell Source, Inc. was founded in 2012 and is headquartered in New York, ...[Read more]
Industry
Biotechnology
IPO Date
2014-05-01
Stock Exchange
OTC
Ticker
CLCS
According to Cell Source, Inc.’s latest financial reports and current stock price. The company's current ROE is 19.05%. This represents a change of 184.02% compared to the average of 6.71% of the last 4 quarters.
The mean historical ROE of Cell Source, Inc. over the last ten years is 46.10%. The current 19.05% ROE has changed -58.68% with respect to the historical average. Over the past ten years (40 quarters), CLCS's ROE was at its highest in in the March 2019 quarter at 28.54%. The ROE was at its lowest in in the December 2016 quarter at -21.74%.
Average
46.10%
Median
43.26%
Minimum
15.51%
Maximum
77.94%
Discovering the peaks and valleys of Cell Source, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 336.29%
Maximum Annual ROE = 77.94%
Minimum Annual Increase = -64.34%
Minimum Annual ROE = 15.51%
| Year | ROE | Change |
|---|---|---|
| 2024 | 25.38% | -25.53% |
| 2023 | 34.08% | -16.68% |
| 2022 | 40.91% | -26.54% |
| 2021 | 55.69% | -2.94% |
| 2020 | 57.38% | -26.38% |
| 2019 | 77.94% | 81.13% |
| 2018 | 43.03% | -36.40% |
| 2017 | 67.65% | 336.29% |
| 2016 | 15.51% | -64.34% |
| 2015 | 43.49% | -59.44% |
The current ROE of Cell Source, Inc. (CLCS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
33.46%
5-year avg
42.69%
10-year avg
46.10%
Cell Source, Inc.’s ROE is less than Zenith Capital Corp. (135.42%), greater than Synairgen plc (-51.06%), greater than Quest PharmaTech Inc. (-1.09%), less than Gemina Laboratories Ltd. (107.27%), greater than Propanc Biopharma, Inc. (-601.00%), less than AccuStem Sciences Limited (55.06%), greater than Telescope Innovations Corp. (-33.79%), less than Hemostemix Inc. (68.24%), less than Sirona Biochem Corp. (221.45%), greater than Hadasit Bio-Holdings Ltd (-184.02%),
| Company | ROE | Market cap |
|---|---|---|
| 135.42% | $11.15M | |
| -51.06% | $110.27K | |
| -1.09% | $4.82M | |
| 107.27% | $13.02M | |
| -601.00% | $10.63M | |
| 55.06% | $0 | |
| -33.79% | $13.64M | |
| 68.24% | $10.66M | |
| 221.45% | $5.60M | |
| -184.02% | $1.33M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cell Source, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cell Source, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Cell Source, Inc.'s ROE?
How is the ROE calculated for Cell Source, Inc. (CLCS)?
What is the highest ROE for Cell Source, Inc. (CLCS)?
What is the 3-year average ROE for Cell Source, Inc. (CLCS)?
What is the 5-year average ROE for Cell Source, Inc. (CLCS)?
How does the current ROE for Cell Source, Inc. (CLCS) compare to its historical average?